LIFE - aTyr Pharma: Successful Proof Of Concept In Pulmonary Sarcoidosis December, 28 2021 09:46 AM aTyr Pharma Inc. aTyr's lead candidate ATYR1923 recently came out with strong data in a proof of concept trial. Lead indication has a large market in the US. Company is early stage, but looks highly interesting. For further details see: aTyr Pharma: Successful Proof Of Concept In Pulmonary Sarcoidosis